Log In
Print this Print this

Genevax IL-12 pDNA adjuvant

  Manage Alerts
Collapse Summary General Information
Company Profectus BioSciences Inc.
DescriptionPlasmid DNA vector that expresses the p40 and p35 subunits of human IL-12
Molecular Target
Mechanism of Action 
Therapeutic ModalityAdjuvant
Latest Stage of DevelopmentPhase I
Standard IndicationHIV / AIDS
Indication DetailsPrevent HIV infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today